Emergence of reduced susceptibility and resistance to fluoroquinolones in Escherichia coli in Taiwan and contributions of distinct selective pressures

Antimicrobial Agents and Chemotherapy

Volumn 45, Issue 11, 2001, Pages 3084-3091

  McDonald, L C ^a   Chen, F J ^a   Lo, H J ^a   Yin, H C ^a   Lu, P L ^a   Huang, C H ^a   Chen, P ^a   Lauderdale, T L ^a   Ho, M ^a  

^a NATIONAL HEALTH RESEARCH INSTITUTES   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

DNA TOPOISOMERASE (ATP HYDROLYSING) A; GENE PRODUCT; QUINOLINE DERIVED ANTIINFECTIVE AGENT; UNCLASSIFIED DRUG;

ADULT; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM ISOLATION; CANCER; COMORBIDITY; CONTROLLED STUDY; DRUG EXPOSURE; ENTEROBACTER INFECTION; ESCHERICHIA COLI; HOSPITAL INFECTION; HUMAN; INTENSIVE CARE; MAJOR CLINICAL STUDY; OUTPATIENT; POINT MUTATION; PRIORITY JOURNAL; RISK FACTOR; STRAIN DIFFERENCE; TAIWAN;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTI-INFECTIVE AGENTS; CHILD; DNA GYRASE; DNA TOPOISOMERASE IV; DRUG RESISTANCE, MICROBIAL; EPIDEMIOLOGY, MOLECULAR; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; FEMALE; FLUOROQUINOLONES; GENE FREQUENCY; HUMANS; MALE; MIDDLE AGED; MUTATION; RISK FACTORS; TAIWAN;

EID: 0034774995     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.45.11.3084-3091.2001     Document Type: Article

References (32)

1. Intensive Care Antimicrobial Resistance Epidemiology (ICARE) surveillance report, data summary from January 1996 through December 1997: A report from the National Nosocomial Infections Surveillance (NNIS) system
2. Invasive disease caused by ciprofloxacin-resistant uropathogenic Escherichia coli
3. Ciprofloxacin-resistant Escherichia coli emerging in a rehabilitation medical center
4. Emergence of quinolone-resistant Escherichia coli bacteremia in neutropenic patients with cancer who have received prophylactic norfloxacin
5. gyrA mutations in high-level fluoroquinolone-resistant clinical isolates of Escherichia coli
6. Risk factors for acquisition of urinary, tract infections caused by ciprofloxacin resistant Escherichia coli
7. Occurrence of single-point gyrA mutations among ciprofloxacin-susceptible Escherichia coli isolates causing urinary tract infections in Latin America
8. Emergence and dissemination of quinolone-resistant Escherichia coli in the community
9. CDC definitions for nosocomial infections, 1988
10. Increasing resistance to fluoroquinolones in Escherichia coli from urinary tract infections in the Netherlands
11. Quinolones in gastrointestinal infections
12. Characterization of fluoroquinolone-resistant mutants of Escherichia coil selected in vitro
13. Fluoroquinolones
14. Surveillance of antibiotic resistance in Taiwan, 1998
15. Nontarget gene mutations in the development of fluoroquinolone resistance in Escherichia coli
16. Characterization of clinical isolates of Escherichia coli showing high levels of fluoroquinolone resistance
17. The use of antibiotics critical to human medicine in food-producing animals in Taiwan
18. An outbreak of multidrug-resistant, quinolone-resistant Salmonella enterica serotype Typhimurium DT104
19. Treatment options for acute uncomplicated cystitis in adults
20. Molecular epidemiology of fluoroquinolone-resistant Escherichia coli bloodstream isolates from patients admitted to European cancer centers
21. Fluoroquinolone resistance of human pathogenic bacteria. Resistant E. coli now appearing in Sweden
22. Development of a rapid assay for detecting gyrA mutations in Escherichia coli and determination of incidence of gyrA mutations in clinical strains isolated from patients with complicated urinary tract infections
23. Incidence and clinical impact of fluoroquinolone-resistant Escherichia coli in the faecal flora of cancer patients treated with high dose chemotherapy and ciprofloxacin prophylaxis
24. Mechanisms of fluoroquinolone resistance: An update 1994-1998
25. Antimicrobial susceptibilities of blood culture isolates obtained before and after the introduction of ciprofloxacin
26. The global epidemiology of resistance to ciprofloxacin and the changing nature of antibiotic resistance: A 10 year perspective
27. Epidemiology of quinolone resistance. Eastern hemisphere
28. Quinolone-resistant Salmonella typhi in Vietnam: Molecular basis of resistance and clinical response to treatment
29. Genetic characterization of highly fluoroquinolone-resistant clinical Escherichia coli strains from China: Role of acrR mutations
30. gyrA mutations associated with fluoroquinolone resistance in eight species of Enterobacteriaceae
31. Molecular epidemiological analysis of quinolone-resistant Escherichia coli causing bacteremia in neutropenic patients with leukemia in Korea